Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × sargramostim × 30 days × Clear all

Sponsor

Conditions

Neuroblastoma 3 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasm Metastasis 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 7 Bortezomib 5 Cyclophosphamide 4 venetoclax 2 Clinical Protocols 2 pomalidomide 1 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 belantamab mafodotin 1 auricularum 1 X-Rays 1 Specimen Handling 1 Pharmaceutical Preparations 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Calcium Dobesilate 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡